SCHEMBL7777792

SCHEMBL7777792

CSc1ccc(-c2n[nH]c(C(F)(F)F)c2-c2ccc(F)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GYS1 P13807 7/20 0.54
MAPK13 O15264 5/20 0.45
MAPK12 P53778 5/20 0.45
MAPK11 Q15759 5/20 0.45
MAPK14 Q16539 5/20 0.45
GCGR P47871 4/20 0.45
PRKD3 O94806 1/20 0.45
MAP4K4 O95819 1/20 0.45
LCK P06239 1/20 0.45
RET P07949 1/20 0.45
ALOX5 P09917 1/20 0.45
PRKACA P17612 1/20 0.45
RPS6KB1 P23443 1/20 0.45
MATK P42679 1/20 0.45
FRK P42685 1/20 0.45
MAPK9 P45984 1/20 0.45
CSNK1A1 P48729 1/20 0.45
CSNK1D P48730 1/20 0.45
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8953773 0.87 GYS1 (0.54) GYS1MAPK14GCGRMAPTCNR1
SCHEMBL7778156 0.83 PTGS2 (0.48) GYS1LRRK2PTGS1PTGS2
SCHEMBL7777308 0.82 LRRK2 (0.57) GYS1MAPTCNR1CNR2GPR55
SCHEMBL7790904 0.82 PTGS2 (0.43) GYS1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5452750 0.81 LRRK2 (0.58) GYS1MAPK13MAPK12MAPK11MAPK14
SCHEMBL8758913 0.81 SLC5A1 (0.46) GYS1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6252659 0.78 PTGS2 (0.58) GYS1LRRK2PTGS1PTGS2
SCHEMBL8758606 0.77 GYS1 (0.38) GYS1MAPK13MAPK12MAPK11MAPK14
SCHEMBL7864515 0.74 MAPK13 (0.42) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL8627994 0.74 LRRK2 (0.46) GYS1MAPTCNR1CNR2GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed